Yue Ning Selected Research

jujuboside A

6/2022

Increased expression of FAT4 suppress metastasis of lung adenocarcinoma through regulating MAPK pathway and associated with immune cells infiltration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yue Ning Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 09/2019
6	Neoplasm Metastasis (Metastasis) 06/2022 - 08/2020
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 09/2019
4	Adenocarcinoma of Lung 06/2022 - 09/2019
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 06/2022 - 01/2021
3	Carcinogenesis 01/2021 - 01/2021
2	Lymphatic Metastasis 10/2020 - 09/2019
1	Fibrosis (Cirrhosis) 07/2021
1	Nasopharyngeal Carcinoma 01/2021
1	Lung Neoplasms (Lung Cancer) 08/2020
1	Pathologic Processes 01/2020
1	Infections 01/2017
1	Lipidoses 01/2013
1	Birth Weight (Birth Weights) 08/2007
1	Lung Diseases (Lung Disease) 08/2007
1	Bronchopulmonary Dysplasia 08/2007

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 06/2022 - 08/2007
5	Messenger RNA (mRNA)IBA 06/2022 - 10/2020
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2019
2	Phosphotransferases (Kinase)IBA 01/2022 - 08/2020
2	Everolimus FDA Link 01/2022 - 01/2020
1	Small Interfering RNA (siRNA)IBA 06/2022
1	jujuboside AIBA 06/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Eukaryotic Initiation Factor-4EIBA 01/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2022
1	Mitogen-Activated Protein KinasesIBA 01/2022
1	B7-H1 AntigenIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Programmed Cell Death 1 ReceptorIBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	Prolyl Hydroxylases (Prolyl Hydroxylase)IBA 01/2021
1	LigandsIBA 01/2021
1	CateninsIBA 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	tyrosine receptor (receptor, tyrosine)IBA 08/2020
1	Indicators and Reagents (Reagents)IBA 08/2020
1	MucinsIBA 08/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2017
1	CholesterolIBA 01/2013
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2007
1	Surface-Active Agents (Surfactants)IBA 08/2007

Therapy/Procedure

3	Therapeutics 07/2021 - 01/2020
1	Aftercare (After-Treatment) 01/2022
1	Immunotherapy 01/2021
1	Drug Therapy (Chemotherapy) 01/2020
1	Radiotherapy 09/2019